Ai Medchem platform development
In progress
AiB-001 Project
New Liver Targeted Orally-available Inhibitors of HBV Polymerase.
At lead optimisation/preclinical candidate stage.
Program ready for early co-development/license, contact us for information.
AiB-002 Project
Drug design stage
